US Patent 10328126 Peptides and compositions for treatment of joint damage
Patent 10328126 was granted and assigned to Novartis on June, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+239 characters)
Article
Patent abstract
The present invention provides new protease-resistant polypeptides, as well as compositions and methods for treating, ameliorating or preventing conditions related to joint damage, including acute joint injury and arthritis.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jian Shi0
Kristen Johnson0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
103281260
Date of Patent
June 25, 2019
0Patent Application Number
154576560
Date Filed
March 13, 2017
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 20 Jul, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 27 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10328126 Peptides and compositions for treatment of joint damage
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10328126
Date of patent
June 25, 2019
Patent application number
15457656
Date Filed
March 13, 2017
Patent primary examiner
Find more entities like US Patent 10328126 Peptides and compositions for treatment of joint damage
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
